Amarin | AMRN - Ordinary Share Capital

Stock Price
14.31
Daily Change
-0.28 -1.92%
Monthly
-2.52%
Yearly
37.20%
Q2 Forecast
13.88

Amarin reported $20.81M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amarin USD 20.81M 13K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
DBV Technologies USD 136.82M 51.98K Sep/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Novartis USD 1.91B 10.64M Dec/2025